T1	Participants 451 583	Patients (N = 207) with nonresectable rectal cancer were randomized to preoperative CRT or RT (2 Gy × 25 ± 5-fluorouracil/leucovorin
T2	Participants 980 1069	Of the 105 patients alive in Norway and Sweden after 4 to 12 years of follow-up, 78 (74%)
